Break the Boundaries Trademark - Pharmaceuticals Class 005
Summary
USPTO published trademark application TM79442531 for "Break the Boundaries" covering pharmaceutical information services, medical research including gene therapy and stem cell services, clinical trials, SaaS/cloud platforms, and medical equipment rentals under Class 005. The application was published April 1, 2026, initiating the standard opposition period.
What changed
The USPTO published trademark application TM79442531 for "Break the Boundaries" under International Class 005 (pharmaceuticals). The application covers pharmaceutical information services, medical and scientific research, gene therapy research, stem cell bank services, regenerative medicine research, clinical trial services, SaaS/platform services, medical equipment rental, and related technology consulting services.
Pharmaceutical companies, healthcare providers, and medical technology firms should review the published goods and services description for potential conflicts with existing trademarks. Third parties wishing to oppose this registration typically have 30 days from publication to file an opposition. No compliance actions are required for entities without conflicting marks.
What to do next
- Review trademark TM79442531 goods and services description for potential conflicts with existing marks
- File opposition within the standard 30-day period if conflict exists
- Consult trademark counsel if clarification needed on scope of protection
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
BREAK THE BOUNDARIES, DELIVER THE FUTURE
Published for Opposition TM79442531 Kind: published Apr 01, 2026
Abstract
Information services in relation to pharmaceuticals; information services in relation to gene therapy; information services in relation to regenerative medicine; medical analysis and provision of medical information in relation to pharmaceuticals and regenerative medical products; provision of medical information containing clinical data of patients; medical analysis and provision of medical information; stem cell bank services; human tissue bank services; cultured cell bank services for medical transplantation; medical screening; medical testing services; provision of health information; health counselling; health care; consulting services in the field of health; dietary and nutritional guidance; rental of medical apparatus and instruments; rental of medical equipment.; Testing, inspection, research or development of pharmaceuticals; providing information, advice and consultancy services relating to testing, inspection, research or development of pharmaceuticals; testing, inspection, research or development of regenerative medical products; providing information, advice and consultancy services relating to testing, inspection, research or development of regenerative medical products; medical and scientific research, namely, conducting clinical trials for others; testing, inspection or research of stem cells; providing information, advice and consultancy services relating to testing, inspection or research of stem cells; testing, inspection or research of gene therapy; providing information, advice and consultancy services relating to testing, inspection or research of gene therapy; testing, inspection or research of medicine in the field of gene therapy; providing information, advice and consultancy services relating to testing, inspection or research of medicine in the field of gene therapy; testing, inspection or research of regenerative medicine; providing information, advice and consultancy services relating to testing, inspection or research of regenerative medicine; testing, inspection or research of medical and medical technology; providing information, advice and consultancy services relating to testing, inspection or research of medical and medical technology; testing, inspection or research of chemicals; testing, inspection or research of biology; research and development of pharmaceuticals and regenerative medical products for others; research and development of new products for others; scientific research; scientific laboratory services; testing, inspection, research or development of medical apparatus and instruments; providing information, advice and consultancy services relating to testing, inspection, research or development of medical apparatus and instruments; testing, inspection or research on functionality of machines, apparatus and instruments; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing information, advice and consultancy services relating to testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; software as a service [SaaS]; platform as a service [PaaS]; server hosting; electronic data storage; providing temporary use of non-downloadable computer programs on data networks; computer system design; development of computer platforms; software engineering services for data processing; computer programming services; computer software design, computer programming, and maintenance of computer software; off-site data backup; recovery of computer data; computer security consultancy; telecommunication network security consultancy; information technology (IT) support services, namely troubleshooting of computer software problems.; Biological tissue cultures for medical purposes or veterinary purposes; cells for medical purposes; living cells for medical purposes or veterinary purposes; stem cells for medical purposes or veterinary purposes; cell culture media for medical purposes or veterinary purposes; cell culture reagents for medical purposes o...
Filing Date
2025-11-27
Related changes
Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.